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ABSTRACT 
Objective: Inflammation can be induced by microbiological, chemical, physical factors and plays roles in inflammatory diseases. Turmeric (Curcuma 
longa L.) has been widely used to provide a diverse array of biological activities, including anti-inflammatory, antimicrobial, also antioxidant. The 
Turmeric extract (TE) anti-inflammatory potential was conducted using a Lipopolysaccharide (LPS)-induced RAW264.7 macrophage cell line by 
inhibiting inflammatory mediators especially IL-6, PGE-2, IL-1β, COX-2, TNF-α, iNOS, also NO level.  
Methods: The TE safe concentration in LPS-induced macrophage cell line was measured using MTS assay for further assay. The inflammatory 
markers (IL-6, PGE-2, COX-2, IL-1β, TNF-α, iNOS, NO) were measured using ELISA assay and NO by the nitrate/nitrite colorimetric assay in LPS-
induced RAW264.7 cell line. LPS induced inflammatory marker by increasing inflammatory marker (IL-6, PGE-2, COX-2, IL-1β, TNF-α, iNOS, NO).  
Results: TE with 100 to 25 µg/ml, caused a significant reduction of cells viability, reaching only 30.27 % live cells. TE with lower concentrations 
(7.5; 5; 2.5 µg/ml) had no cytotoxic effect on macrophage cells (viability 117.31-131.08 %). LPS induction caused an increase in inflammatory 
cytokines IL-1β, PGE-2, IL-6, COX-2, TNF-α as well as iNOS and NO. Turmeric extract caused the reduction of the inflammatory cytokines in a dose-
dependent manner. 
Conclusion: The research resulted that TE has anti-inflammatory activity by decreasing IL-6, PGE-2, COX-2, IL-1β, TNF-α, iNOS, and NO level on 
LPS-induced RAW264.7 cells.  
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INTRODUCTION 
Inflammation is the host natural defence against pathogen infections, 
which also can be induced by microbiological, chemical, physical factors 
[1-3]. Inflammation involves several events such as changes in blood 
flows and vascular permeability, activation and migrations of leukocytes, 
and synthesis of local inflammatory mediators. The inflammatory 
mediators such as interleukin (IL)-1β, prostaglandin E2 (PGE2), IL-6, 
tumor necrosis factor-alpha (TNF-α), cyclooxygenase-2 (COX-2), and 
nitric oxide (NO) has been observed as the primary response to 
inflammation [4, 5]. Prolonged exposure to these inflammatory 
mediators may induce acute and/or chronic inflammatory responses in 
the organs such as heart, lung, brain, and reproductive systems and 
potentially leading to tissues damage [4, 6, 7]. Increased level of TNF-α 
elicited platelet activation when during inflammation the complement is 
activated on the surface of platelet [8, 9] meanwhile burst of IL-1β are 
involved in acute attack of systemic or local inflammation [10] and IL-6 
trans signal mediate inflammation from acute to chronic [11]. To treat 
the inflammatory related disease, abundance research has been 
conducted to find potential anti-inflammatory compounds, including 
plants-derived compounds. Turmeric (Curcuma longa L) has been 
used as traditional therapy over the years, including in the ayuverdic 
medication. Turmeric has been provided scientifically against such 
human ailments [12]. Turmeric contains active compounds, 
classified as curcuminoids, consist of curcumin (77%), 
bisdemethoxycurcumin (3%) and demethoxycurcumin (17%). 
Curcumin has been stated as major biologically active components 
having anti-bacterial, anti-diabetic, anti-oxidant, anti-inflammatory 
activities, lowering cholesterol [13]. 
The widely used as inflammatory cells model in vitro was murine 
macrophage cell line (RAW 264.7). While lipopolysaccharide (LPS) 
as bacterial metabolite is one of the well-studied stimulus to induce 
inflammatory mediators’ secretion. In the current study, we focused 
on the turmeric extract (TE) potential anti-inflammatory activity by 
modulating the pro-inflammatory molecules production (TNF-α, 
PGE-2, IL-1β, iNOS, IL-6, COX-2, and NO). 
MATERIALS AND METHODS  
Materials 
Turmeric (C. longa L.) rhizome was collected from farmer plantation in 
Bogor, West Java, Indonesia. The murine macrophage cell line (RAW 
264.7, ATCC TIB-71) was obtained from Biomolecular and Biomedical 
Research Center, Aretha Medika Utama, Bandung, Indonesia. Dulbecco’s 
Modified Eagle Medium (DMEM) (from Biowest, L0104), 10% fetal 
bovine serum (FBS) (from Biowest, S1810-500), 1% Antibiotic/ 
antimycotic (ABAM, from Biowest, L0010-100), 1% Nanomycopulitine 
(from Biowest, L-X16-010), and 0.1% Gentamicin (from Gibco 
15750078). Bovine Standard Albumin (BSA) (from Sigma Aldrich, 
A9576). Quick Start Dye Reagent 1X (from Biorad, 5000205). LPS from 
Escherichia coli (Sigma Aldrich, L2880), MTS (3-(4,5-dimethylthiazol-2-
yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)-2H-tetrazolium) 
(from Abcam, ab197010), Elisa Kit mouse IL-1β (E-EL-M0037), mouse 
TNF-α (E-EL-M0049), mouse COX-2 (E-EL-M0959), mouse IL-6 (E-EL-
M0044), PGE-2 (E-EL-0034), mouse iNOS (E-EL-M0696), NO 
Colorimetric Assay (E-BC-K035-M). 
Methods 
Extraction process 
Turmeric (Curcuma longa L.) rhizome was identified by herbarium 
staff of Scholl of Life Sciences, Bandung Institute of Technology, 
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Bandung, West Java, Indonesia. One kilogram of dried rhizome 
powder was macerated using distilled ethanol, filtered, and 
evaporated by rotary evaporator (Zhengzhou Well-known, RE-
201D). The turmeric extract (TE) in the form of paste was stored at-
20 °C until further use [14]. 
Cells culture 
Cells that used in this study (murine macrophage cell line also 
known as RAW 264.7) was cultured in DMEM, ABAM, FBS, 
Gentamicin, and Nanomycopulitine then incubated at 37 °C in a 
humidified atmosphere with 5% CO2. When the cells was at 80% 
confluency, it was harvested using cells scrapper [15-18]. 
Cells viability measurements 
MTS assay was used to measured murine macrophage cell line 
viability. In 96 well-plates, cells (5x103 cells/well) were planted in 
180 µl growth medium also extract with various concentrations 
(100; 75; 50; 25; 7,5; 5; 2.5; 0 µg/ml) as much as 20 µl, then 
incubated in 37 °C with CO2 5% for 24 h. Then the reagent (MTS) 
was added into each well and incubated at the same condition for 3 
h. At the wavelength of 490 nm in a microplate reader (Multiskan Go, 
Thermo Scientific), the absorbance was read using and cells viability 
was calculated [10-14].  
LPS-induced RAW cells and treatments 
In 6 well plate, cells (5x105 cells/well) were planted and incubated for 
24 h. It was treated with TE and induced by LPS. Six treatments that 
used for this research: (1) the negative control (without induced by 
LPS); (2) positive control (induced by 1 μg/ml LPS); (3) macrophage 
cells that induced by 1 μg/ml LPS and treated by TE at 7.5 μg/ml; (4) 
macrophage cells that induced by 1 μg/ml LPS and treatetd by TE at 
5 μg/ml; (5) macrophage cells that induced by 1 μg/ml LPS and 
treated by TE 2.5 µg/ml. It was incubated for another 24 h. After that, 
the conditioned medium was collected. It was centrifuged and 
collected the cell-free supernatant that used for measure the COX-2, IL-
1β, TNF-α, IL-6, PGE-2, iNOS, and NO level [15-19].  
Measurement of IL-1β, TNF-α, COX-2, IL-6, PGE-2, and iNOS level 
ElabScience Elisa Kit was used to measure the IL-1β, TNF-α, COX-2, 
IL-6, PGE-2, iNOS level used under manufacture protocols [15-22].  
Measurement of NO level 
The nitrite associated with NO production was measured using NO 
Colorimetric Assay that performed based on manufacture protocols. 
The Sodium Nitrite Standard curve was determined to measure the 
nitrite quantity [15-17]. 
Statistical analysis 
SPSS software (IBM SPSS 22) were used to statistically analysed the 
data. The statistical significance among treatments was evaluated 
using One-way Analysis of Variance (ANOVA) followed by Tukey 
HSD post hoc test with p<0,05. 
RESULTS AND DISCUSSION 
The cytotoxic effect of TE toward macrophage cells were done to 
determine the safe extract concentration. TE with 100 to 25 µg/ml, 
caused a significant reduction of cells viability, reaching only 30.27 
% live cells. The lower concentrations of TE (2.5; 5; 7.5 µg/ml) was 
showed no cytotoxic effect on macrophage cells (viability 117.31-
131.08 %) (fig. 1). 
  
 
Fig. 1: Effect of turmeric extract on RAW 264.7 cells viability,  
The data was presented as mean+standard deviation that has been analysed by using Tukey HSD post hoc test at p<0.05. Single asterisk 
(*) shows significant differences compared to control. 
 
LPS induction caused increase in inflammatory cytokines such as 
TNF-α (fig. 2a), IL-6 (fig. 2b), IL1-β (fig. 2c), PGE-2 (fig. 2d), COX-2 
(fig. 2e) as well as iNOS (fig. 2f) and NO (fig. 2g). TE reduced the 
inflammatory cytokines in dose-dependent manner. The main 
mechanism of TE action is by curcumin content which has been 
shown in various inflammatory models such as macrophage [24, 25, 
32], microglial cells [26, 28, 29, 31] induced by LPS, and macrophage 
cells induced by adipocyte conditioned medium from obesity 
patients [27, 30]. 
LPS induces macrophage activation through extracellular region of 
Toll-Like receptor 4 (TLR4) [33]. The activated TLR4 will activate 
cascades events in the cytoplasm which leads to MAPK (JNK, 
ERK1/2, p38) pathway activation. The phosphorylated MAPKs 
causes phosphorylation of inhibitory factor kappa B (IkB) which 
leads to  nuclear factor-kappa B (NFkB) activation, followed by its 
translocation to the nucleus. NFκB is a ubiquitous transcription 
factor that controls genes expression involved in apoptosis, immune 
responses, and cell cycle [34].  
Exposure LPS to cells leads the dimerization of NFκB which leads to 
inflammatory related genes activation such as IL-1β, TNF-α, PGE-2, 
IL-6, iNOS, also COX-2 [35, 36]. TNF-α and IL-1β is the innate 
immune response mediator which leads to other inflammatory 
cytokines secretion. TNF-α induces leukocytes adhesion molecules 
expression, leading to diapedesis through vascular endothelial cells. 
IL-6 mainly acts in acute response and activation of lymphocytes’ 
antibody secretion [23, 35, 36] JNK signaling cascade regulates LPS-
stimulated iNOS expression [35]. Meanwhile iNOS is an enzyme that 
produces NO [5]. NO is synthesized and released into the endothelial 
cells and mediates vasodilatation which helps leukocytes migration 
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Fig. 2: Turmeric extract effect in LPS-stimulated macrophage cells toward inflammatory marker, data is presented as mean+standard 
deviation that has been analysed using Tukey HSD post hoc test (p<0.05). Single asterisk symbol (*) shows significant differences among 
treatment compared to positive control and hashtag symbol (#) shows significant differences between positive control and negative 
control. All groups were conducted in triplicate. (a) TNFα level, (b) IL-6 level, (c) IL-1β level, (d) PGE-2 level, (c) COX-2 level, (f) iNOS level, 
(g) NO level 
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Turmeric extract mainly acts through curcumin which has been 
widely studied and has been known to have anti-inflammatory 
properties through several molecules inhibition. Curcumin causes 
inhibition of inflammatory-related kinases such as JNK, ERK, MAPK, 
transcription factors such as NFκB, enzymes such as iNOS, as well as 
the inflammatory cytokines such as IL-6, TNF-α, and IL-1 [37]. Our 
results suggest that TE could inhibit the LPS-induced inflammatory 
marker including NO, PGE-2, TNF-α, IL-1β, COX-2, IL1-β, IL-6, iNOS 
level. We proposed the mechanism of action anti-inflammatory 
property of TE based on our result and literature review in fig. 3. 
     
Fig. 3: Proposed mechanism of LPS-induced inflammation inhibition by turmeric extract 
 
CONCLUSION 
Turmeric extract has a potential as anti-inflammatory by decreasing 
TNF-α, IL-6, PGE-2, COX-2, IL-1β, NO and iNOS. While this research 
could be used as a reference for anti-inflammatory activity of 
turmeric in vitro research, further research by in vivo and clinical 
trial is needed for confirmation of the result. 
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